New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: RadioShack Corporation (NYSE:RSH), VIVUS, Inc (NASDAQ:VVUS), Sequenom, Inc (NASDAQ:SQNM), Integrated Device Technology Inc (NASDAQ:IDTI)
RadioShack Corporation (NYSE:RSH) showed a volume of 1.39 million shares by the end of last trade whereas the average volume of the stock remained 1.72 million shares. The stock opened the session at $2.65 but then moved to $2.65. At that price, the stock showed a positive performance of 0.38%. RadioShack Corporation (RadioShack) is engaged in the retail sale of consumer electronics goods and services through its RadioShack store chain. The Company’ segments include U.S. Radioshack Company-Operated Stores and Others. As of December 31, 2012, the Company operated 4,395 U.S. company-operated stores under the RadioShack brand located throughout the United States, as well as in Puerto Rico and the U.S.
Will RSH Continue To Move Higher? Find Out Here
VIVUS, Inc (NASDAQ:VVUS) opened the session at $9.35 and closed the session at $9.55. The stock showed a positive performance of 1.49% in previous trading session. Traded with volume of 1.37 million shares in the prior session and the average volume of the stock remained 1.64 million shares. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese),
For How Long VVUS will fight for Profitability? Read This Trend Analysis report
Sequenom, Inc (NASDAQ:SQNM) opened the session at $2.35 and closed the session at $2.43. The stock showed a positive performance of 4.29% in previous trading session. Traded with volume of 1.37 million shares in the prior session and the average volume of the stock remained 1.80 million shares. The beta of the stock remained 0.40. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications,
Why Should Investors Buy SQNM After The Recent Gain? Just Go Here and Find Out
Integrated Device Technology Inc (NASDAQ:IDTI) the stock decreased -0.50% and finished the session at $9.98. Traded with volume of 1.36 million shares in the prior session and the average volume of the stock remained 1.49 million shares. The beta of the stock remained 1.66. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries. The Company operates in the Communications segment and the Computing and Consumer segment. The Company offers communications solutions for customers within the enterprise, data center and wireless markets.
Will IDTI Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)